More than a million patients who have had a myocardial infarction or stroke and are overweight will now be eligible for weight loss jabs on the NHS after a new NICE technology appraisal recommended their use.
A weekly injection of the weight loss drug semaglutide (brand name Wegovy) can be offered to individuals who have had a myocardial infarction, a stroke or have sy...